Literature DB >> 28838979

Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Markus Glatzer1, Achim Rittmeyer2, Joachim Müller3, Isabelle Opitz4, Alexandros Papachristofilou5, Ioannis Psallidas6,7, Martin Früh8, Diana Born9, Paul Martin Putora10.   

Abstract

Small cell lung cancer (SCLC) presents multiple interdisciplinary challenges with several paradigm shifts in its treatment in recent years. SCLC treatment requires multidisciplinary management and timely treatment. The aim of this review is to focus on the team management aspects in the treatment of limited disease SCLC and how this can contribute towards improving outcomes.
Copyright ©ERS 2017.

Entities:  

Mesh：

Year:  2017        PMID： 28838979     DOI： 10.1183/13993003.00422-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


  109 in total

1.  Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).

Authors:  Ryosuke Tsuchiya; Kenji Suzuki; Yukito Ichinose; Yoh Watanabe; Tsutomu Yasumitsu; Naoki Ishizuka; Harubumi Kato
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

2.  Vascular and cognitive functions associated with cardiovascular disease in the elderly.

Authors:  Ronald A Cohen; Athena Poppas; Daniel E Forman; Karin F Hoth; Andreana P Haley; John Gunstad; Angela L Jefferson; David F Tate; Robert H Paul; Lawrence H Sweet; Mokato Ono; Beth A Jerskey; Marie Gerhard-Herman
Journal:  J Clin Exp Neuropsychol       Date:  2008-06-16       Impact factor: 2.475

3.  Management of lung cancer in South East Scotland.

Authors:  R J Fergusson; A Gregor; R Dodds; G Kerr
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

4.  Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).

Authors:  Peter Vilmann; Paul Frost Clementsen; Sara Colella; Mette Siemsen; Paul De Leyn; Jean-Marc Dumonceau; Felix J Herth; Alberto Larghi; Enrique Vazquez-Sequeiros; Cesare Hassan; Laurence Crombag; Daniël A Korevaar; Lars Konge; Jouke T Annema
Journal:  Endoscopy       Date:  2015-06-10       Impact factor: 10.093

Review 5.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

6.  Delays in the diagnosis and surgical treatment of lung cancer.

Authors:  J S Billing; F C Wells
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

Review 7.  Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach.

Authors:  Ravi Salgia
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

8.  Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Paul A Kvale; Paul A Selecky; Udaya B S Prakash
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

9.  The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway.

Authors:  P V Murray; M E R O'Brien; R Sayer; N Cooke; G Knowles; A C Miller; V Varney; N P Rowell; A R Padhani; D MacVicar; A Norton; S Ashley; I E Smith
Journal:  Lung Cancer       Date:  2003-12       Impact factor: 5.705

10.  An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer.

Authors:  L M Forrest; D C McMillan; C S McArdle; D J Dunlop
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640
View more
  7 in total

1.  Causes of death following small cell lung cancer diagnosis: a population-based analysis.

Authors:  Xue-Qin Wu; Jing-Yi Li; Wen-Jing Du
Journal:  BMC Pulm Med       Date:  2022-07-04       Impact factor: 3.320

2.  Quantitative proteomic analysis of mitochondrial proteins differentially expressed between small cell lung cancer cells and normal human bronchial epithelial cells.

Authors:  Wei Li; Wei Zhang; Wenjing Deng; Yujie Zhong; Yonghong Zhang; Zhuo Peng; Haijuan Chen; Ruiying Sun; Xuemei Zhang; Shuanying Yang
Journal:  Thorac Cancer       Date:  2018-09-09       Impact factor: 3.500

Review 3.  The role of radiation therapy in the management of small cell lung cancer.

Authors:  Markus Glatzer; Sabine Schmid; Marco Radovic; Martin Früh; Paul Martin Putora
Journal:  Breathe (Sheff)       Date:  2017-12

4.  A Retrospective Study of Patients with GABABR Encephalitis: Therapy, Disease Activity and Prognostic Factors.

Authors:  Xiangchuan Wen; Baojie Wang; Chunjuan Wang; Chenglin Han; Shougang Guo
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-18       Impact factor: 2.570

5.  Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps.

Authors:  Sebastian Johannes Müller; Eya Khadhraoui; Nicole E Neef; Christian Heiner Riedel; Marielle Ernst
Journal:  BMC Med Imaging       Date:  2021-04-15       Impact factor: 1.930

6.  Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study.

Authors:  Seo Ree Kim; Ji Hyung Hong; Soo-Yoon Sung; Yeo Hyung Kim; Sang Hoon Chun; Hyun Woo Lee; Jung Soo Lee; Yoon Ho Ko
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

7.  Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis.

Authors:  Yang Yang; Danhong Zhang; Xia Zhou; Wuan Bao; Yonglin Ji; Liming Sheng; Lei Cheng; Ying Chen; Xianghui Du; Guoqin Qiu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.